We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioLineRx, MaRS Innovation Sign Framework Collaboration Agreement

News   May 17, 2016

 
BioLineRx, MaRS Innovation Sign Framework Collaboration Agreement
 
 
Advertisement
 

RELATED ARTICLES

Study Investigates Potential Impact of Variant on COVID-19 Vaccine

News

Scientists are investigating whether neutralizing antibodies generated by current COVID-19 vaccines are able to recognize the B.1.1.7 SARS-CoV-2 variant. A new preprint shared by BioNTech and Pfizer outlines one such body of work.

READ MORE

Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe

News

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project.

READ MORE

Tracking AAV Gene Transfer Vector Biodistribution

News

The biodistribution of adeno-associated virus (AAV) gene transfer vectors can be measured in nonhuman primates using a new method. The method quantifies whole-body and organ-specific AAV capsids from 1 to 72 hours after administration.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE